Literature DB >> 23707834

Efficacy of stellate ganglion block in the treatment of anxiety symptoms from combat-related post-traumatic stress disorder: a case series.

Justin Alino1, Donald Kosatka, Brian McLean, Kenneth Hirsch.   

Abstract

OBJECTIVE: Report the efficacious use of stellate ganglion blocks (SGBs) in treating the anxiety symptoms of four patients diagnosed with combat-related post-traumatic stress disorder (PTSD) and discuss possible mechanisms of action to explain these findings.
BACKGROUND: Successful treatment of PTSD with SGB has been demonstrated and reported previously at Walter Reed Army Medical Center. An identical protocol was used at Tripler Army Medical Center to treat four service members diagnosed with combat-related PTSD.
METHODS: All patients reported received an SGB on the right side at the level of C6. The patient's PTSD symptoms were evaluated using the Post-traumatic Stress Disorder Checklist (PCL). This checklist was distributed one day before treatment and again the day following treatment. The patients were also given the PCL at subsequent follow-up visits to quantify sustained benefit.
RESULTS: SGB showed acute benefit for the symptoms of PTSD by markedly reduced PCL scores after the procedure. Benefits were also sustained during close outpatient follow-up.
CONCLUSION: Selective blockade of the right stellate ganglion at C6 is a minimally invasive procedure with an excellent safety profile that may provide sustained relief of PTSD symptoms. The procedure may also provide benefit for those who are resistant to psychotropic intervention. Reprint &
Copyright © 2013 Association of Military Surgeons of the U.S.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23707834     DOI: 10.7205/MILMED-D-12-00386

Source DB:  PubMed          Journal:  Mil Med        ISSN: 0026-4075            Impact factor:   1.437


  9 in total

1.  Successful use of stellate ganglion block and a new centrally acting analgesic with dual mode of action in a resistant temporomandibular joint pain.

Authors:  Gareth Peter Jones; Shiva Shankar Tripathi
Journal:  BMJ Case Rep       Date:  2014-05-20

Review 2.  Possible Reversal of PTSD-Related DNA Methylation by Sympathetic Blockade.

Authors:  Eugene G Lipov; Kenneth Candido; Elspeth C Ritchie
Journal:  J Mol Neurosci       Date:  2017-03-31       Impact factor: 3.444

Review 3.  A review of the use of stellate ganglion block in the treatment of PTSD.

Authors:  Eugene Lipov; Elspeth Cameron Ritchie
Journal:  Curr Psychiatry Rep       Date:  2015-08       Impact factor: 5.285

4.  Safety and Patient Acceptability of Stellate Ganglion Blockade as a Treatment Adjunct for Combat-Related Post-Traumatic Stress Disorder: A Quality Assurance Initiative.

Authors:  Brian McLean
Journal:  Cureus       Date:  2015-09-10

Review 5.  Stellate Ganglion Block for Psychiatric Disorders: A Systematic Review of the Clinical Research Landscape.

Authors:  Jaimie Kerzner; Helen Liu; Ilya Demchenko; David Sussman; Duminda N Wijeysundera; Sidney H Kennedy; Karim S Ladha; Venkat Bhat
Journal:  Chronic Stress (Thousand Oaks)       Date:  2021-12-08

6.  Utility of stellate ganglion block in atypical facial pain: a case report and consideration of its possible mechanisms.

Authors:  Harsha Shanthanna
Journal:  Case Rep Med       Date:  2013-08-26

7.  Stellate ganglion block and cardiac sympathetic denervation in patients with inappropriate sinus tachycardia.

Authors:  Yong-Mei Cha; Xuping Li; Mei Yang; Jie Han; Gang Wu; Suraj C Kapa; Christopher J McLeod; Peter A Noseworthy; Siva K Mulpuru; Samuel J Asirvatham; Peter A Brady; Richard H Rho; Paul A Friedman; Hon-Chi Lee; Ying Tian; Shenghua Zhou; Thomas M Munger; Michael J Ackerman; Win-Kuang Shen
Journal:  J Cardiovasc Electrophysiol       Date:  2019-11-06

8.  Stellate ganglion block treats posttraumatic stress: An example of precision mental health.

Authors:  James H Lynch
Journal:  Brain Behav       Date:  2020-08-28       Impact factor: 2.708

9.  Behavioral health clinicians endorse stellate ganglion block as a valuable intervention in the treatment of trauma-related disorders.

Authors:  James H Lynch; Peter D Muench; John C Okiishi; Gary E Means; Sean W Mulvaney
Journal:  J Investig Med       Date:  2021-03-16       Impact factor: 2.895

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.